Drugs & Therapy Perspectives

, Volume 12, Issue 1, pp 8–11 | Cite as

Ascites often associated with poor prognosis in patients with cirrhosis

New Drugs and Disease Management


Adis International Limited Cirrhotic Patient Transjugular Intrahepatic Portosystemic Shunt Ascitic Fluid Diuretic Therapy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Bataller R, Ginès P, Arroyo V. Practical recommendations for the treatment of ascites and its complications. Drugs 1997 Oct; 54(4): 571–80PubMedCrossRefGoogle Scholar
  2. 2.
    Podolsky DK, Isselbacher KJ. Alcohol-related liver disease and cirrhosis. In: Isselbacher KJ, Martin JB, Braunwald E, et al., editors. Harrison’s principles of internal medicine. 13th ed. New York: McGraw-Hill, 1994: 1483–94Google Scholar
  3. 3.
    Llach J, Ginès P, Arroyo V, et al. Prognostic value of arterial pressure, endogenous vasoactive systems, and renal function in cirrhotic patients admitted to the hospital for the treatment of ascites. Gastroenterology 1988; 94: 482–7PubMedGoogle Scholar
  4. 4.
    Titó LI, Ginès P, Arroyo V, et al. Total paracentesis is associated with intravenous albumin in the management of patients with cirrhosis and ascites. Gastroenterology 1990; 98: 146–51PubMedGoogle Scholar
  5. 5.
    Fernández-Esparrach G, Guevera M, Sort P, et al. Diuretics requirements after therapeutic paracentesis in non-azotemic patients with cirrhosis: a randomized double-blind trial of spironolactone versus placebo. J Hepatol 1997; 26: 614–20PubMedCrossRefGoogle Scholar
  6. 6.
    Ginès A, Fernández-Esparrach G, Monescillo A, et al. Randomized trial comparing albumin, Dextran-70 plus polygeline in cirrhotic patients with ascites treated with paracentesis. Gastroenterology 1996; 111: 1002–10PubMedCrossRefGoogle Scholar
  7. 7.
    Arroyo V, Navasa M, Rimola A. Spontaneous bacterial peritonitis in liver cirrhosis: treatment and prophylaxis. Infection 1994; 22 Suppl. 3: S1–8Google Scholar
  8. 8.
    Navasa M. Treatment of spontaneous bacterial peritonitis and other severe bacterial infections in the setting of cirrhosis. In: Arroyo V, Bosch J, Rodés J, editors. Treatments in hepatology. Barcelona: Masson, 1995; 109–13Google Scholar
  9. 9.
    Runyon B. Diagnosis of bacterial infections in the setting of liver disease. In: Arroyo V, Bosch J, Rodés J, editors. Treatments in hepatology. Barcelona: Masson, 1995; 93–8Google Scholar
  10. 10.
    Andreu M, Solá R, Sitges-Serra A, et al. Risk factors for spontaneous bacterial peritonitis. Gastroenterology 1993; 104: 1133–8PubMedGoogle Scholar
  11. 11.
    Titó LI, Rimola A, Ginès P, et al. Recurrence of spontaneous bacterial peritonitis in cirrhosis: frequency and predictive factors. Hepatology 1988; 8: 27–31PubMedCrossRefGoogle Scholar
  12. 12.
    Arroyo V, Rodés J, Gutierrez-Lizarranga MA, et al. Prognostic value of spontaneous hyponatremia in cirrhosis with ascites. Am J Dig Dis 1976; 21: 249–56PubMedCrossRefGoogle Scholar
  13. 13.
    Arroyo V, Ginès P, Gerbes A, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. Hepatology 1996; 23: 164–76PubMedCrossRefGoogle Scholar
  14. 14.
    Ginès A, Escorsell A, Ginès P, et al. Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites. Gastroenterology 1993; 105: 229–36PubMedGoogle Scholar
  15. 15.
    Gonwa TA, Wilkinson AH. Liver transplantation in patients with and without hepatorenal syndrome. In: Epstein M, editor. The kidney in liver disease. Philadelphia: Hanmley and Belfus, 1996; 529–42Google Scholar
  16. 16.
    Ochs A, Rössle M, Haag K, et al. The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites. N Engl J Med 1995; 332: 1192–7PubMedCrossRefGoogle Scholar
  17. 17.
    Guevara M, Ginès P, Fernández-Esparrach G, et al. Reversal of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion [abstract]. J Hepatol 1997; 26: 104Google Scholar

Copyright information

© Adis International Limited 1998

Personalised recommendations